Overview

Validation of ICG to Identify the Urethra During Rectal Surgery

Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
0
Participant gender:
Male
Summary
This is an open-label feasibility study utilising direct instillation of ICG into the urethra during surgery for low rectal cancers. The trial involves a single intervention taking place during the patient's operation. Participants will be included in the study for around 2 months with time either side of the intervention to collect background data.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Oxford University Hospitals NHS Trust
Collaborator:
University of Oxford
Criteria
Inclusion Criteria:

- Participant is willing and able to give informed consent for participation in the
study.

- Male, aged 18 years or above.

- Undergoing low rectal surgery where the operating field will be close to the urethra

Exclusion Criteria:

- Participant has an allergy to iodine or ICG

- Known liver failure